Abstract:Copper is an element required for cell proliferation and angiogenesis. Human prostate cancer xenografts with increased Cu-64 radioactivity were visualized previously by PET using (CuCl2)-Cu-64 as a radiotracer ((CuCl2)-Cu-64 PET). This study aimed to determine whether the increased tumor 64Cu radioactivity was due to increased cellular uptake of 64Cu mediated by human copper transporter 1 (hCtr1) or simply due to nonspecific binding of ionic 64CuCl2 to tumor tissue. In addition, the functional role of hCtr1 in proliferation of prostate cancer cells and tumor growth was also assessed. Methods: A lentiviral vector encoding short-hairpin RNA specific for hCtr1 (Lenti-hCtr1-shRNA) was constructed for RNA interference-mediated knockdown of hCtr1 expression in prostate cancer cells. The degree of hCtr1 knockdown was determined by Western blot, and the effect of hCtr1 knockdown on copper uptake and proliferation were examined in vitro by cellular 64Cu uptake and cell proliferation assays. The effects of hCtr1 knockdown on tumor uptake of 64Cu were determined by PET quantification and tissue radioactivity assay. The effects of hCtr1 knockdown on tumor growth were assessed by PET/CT and tumor size measurement with a caliper. Results: RNA interference-mediated knockdown of hCtr1 was associated with the reduced cellular uptake of 64Cu and the suppression of prostate cancer cell proliferation in vitro. At 24 h after intravenous injection of the tracer 64CuCl2, the 64Cu uptake by the tumors with knockdown of hCtr1 (4.02 +/- 0.31 percentage injected dose per gram [% ID/g] in Lenti-hCtr1-shRNA-PC-3 and 2.30 +/- 0.59 % ID/g in Lenti- hCtr1- shRNA- DU- 145) was significantly lower than the 64Cu uptake by the control tumors without knockdown of hCtr1 (7.21 +/- 1.48% ID/g in Lenti-SCR-shRNA-PC-3 and 5.57 +/- 1.20% ID/g in Lenti-SCR-shRNA-DU-145, P, 0.001) by PET quantification. Moreover, the volumes of prostate cancer xenograft tumors with knockdown of hCtr1 (179 +/- 111 mm(3) for Lenti-hCtr1-shRNAPC- 3 or 39 +/- 22 mm(3) for Lenti-hCtr1-shRNA-DU-145) were significantly smaller than those without knockdown of hCtr1 (536 +/- 191 mm(3) for Lenti-SCR-shRNA-PC-3 or 208 +/- 104 mm(3) for Lenti-SCR-shRNA-DU-145, P, 0.01). Conclusion: Overall, data indicated that hCtr1 is a promising theranostic target, which can be further developed for metabolic imaging of prostate cancer using (CuCl2)-Cu-64 PET/CT and personalized cancer therapy targeting copper metabolism.

Preparation and Tumor Cell Uptake of Sirna Probe Radiolabeled with Technetium-99m Targeting on Htert Gene

Cellular Uptake Study on Radiolabeled Telomerase-targeted Small Interference RNA in Hepatocarcinoma Cells

[In-Vivo Tumor Imaging by Radiolabeled RNA Probe Targeting Telomerase].

Noninvasive Visualization Of Rna Delivery With Tc-99m-Radiolabeled Small Interference Rna In Tumor Xenografts

Molecular Imaging and Pharmacokinetics of (99m) Tc-hTERT Antisense Oligonucleotide As a Potential Tumor Imaging Probe.

In-vitro Inhibitory Activity and In-vivo Biodistribution of ~(99)Tc~m Radiolabeled Small Interference RNA

Preparation and Characterization of 99Tcm-Labeled Antisense Oligonucleotide Targeting hTERT mRNA

In-vitro Inhibitory Activity and In-Vivo Biodistribution of "9"9tc"m Radiolabeled Small Interference RNA

Noninvasive Imaging of Human Telomerase Reverse Transcriptase (htert) Messenger Rna with (99)Mtc-Radiolabeled Antisense Probes in Malignant Tumors

Reduced 64cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate Cancer.

[Uptake Kinetics of Htert Antisense Molecular Probe by Cells and Its Biological Properities].

A novel molecular probe:experimental study in vivo in nude mice bearing tumor

Study on in vivo imaging of 99Tcm-hTERT mRNA as antisense molecular probe in breast cancer tumor-bearing nude mice

A new fluorescence/PET probe for targeting intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated IgM

Study on Pharmacokinetics and Acute Toxicity of Human Telomerase Reverse Transcriptase Antisense Oligonucleotide Molecular Probe

Improved Synthesis and Biological Evaluation of Tc-99m Radiolabeled Amo for Mirna Imaging in Tumor Xenografts

In Vitro Research on MicroRNA-155 Targeted Radiolabeled Oligonucleotide in Breast Cancer Cells

Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.

A Novel Tc-99m-Labeled Molecular Probe For Tumor Angiogenesis Imaging In Hepatoma Xenografts Model: A Pilot Study

Noninvasive Imaging of C(Rgd)(2)-9r As A Potential Delivery Carrier for Transfection of Sirna in Malignant Tumors

Design and Bio.Evaluation of Cu-64-Nota-Herceptin for Tumor Targeted Micro-Pet Imaging